Oct 29, 6:35 AM ET
Omnicell reported third-quarter 2026 revenue of $308 million, down $3 million, or 1%, from a year earlier, while GAAP net income rose to $11 million, or $0.24 per diluted share, from $5 million, or $0.12. The company raised its full-year 2026 non-GAAP EBITDA and non-GAAP earnings per share guidance, so profit expectations improved even as revenue slipped.
- Q3 2026 non-GAAP net income was $27 million, or $0.58 per diluted share, versus $24 million, or $0.51, in Q3 2025.
- Full-year 2026 non-GAAP EBITDA guidance was raised to $187 million-$193 million; non-GAAP EPS guidance was raised to $2.48-$2.56.
- Full-year 2026 total revenue guidance was tightened to $1.225 billion-$1.231 billion.
- As of September 30, 2026, cash and cash equivalents were $315 million and the company had $350 million of undrawn revolving credit availability.
Read the filing on SEC.gov ↗
Jul 30, 6:34 AM ET
Omnicell reported second quarter 2026 revenue of $312 million, up 7% from a year earlier, and GAAP net income of $24 million, or $0.52 per diluted share, versus $6 million a year earlier. The company raised its full-year 2026 non-GAAP EBITDA and non-GAAP EPS guidance, and narrowed its full-year revenue range to $1.225 billion to $1.245 billion. Results include a $15 million refund of previously paid IEEPA tariffs.
- Q2 2026 non-GAAP EPS was $0.94, up from $0.45; non-GAAP EBITDA was $67 million, up from $38 million
- Full-year 2026 guidance: non-GAAP EBITDA $175 million to $185 million; non-GAAP EPS $2.15 to $2.30
- Q3 2026 total revenue guidance is $301 million to $307 million; full-year product bookings guidance is $425 million to $560 million
- On July 1, 2026, Nnamdi Njoku was named President and Chief Operating Officer
Read the filing on SEC.gov ↗
Jul 1, 8:27 AM ET
Omnicell appointed Nnamdi Njoku as President effective July 1, 2026, while he keeps his role as Chief Operating Officer. Randall Lipps stepped down as President but continues as Chief Executive Officer and Chairman, and Njoku will report to him. The filing describes this as a change in how Omnicell's top leadership duties are divided, with Njoku focused on long-term growth strategy and operational execution.
- Njoku was appointed President effective July 1, 2026, and remains Chief Operating Officer; he had been COO since October 2024
- Lipps stepped down as President; he remains CEO and Chairman with no compensation changes tied to the transition
- Board approved a one-time restricted stock unit award with a target grant date value of approximately $500,000; one-third vests after one year, the rest in equal amounts at two and three years
- Njoku's 2026 base salary is unchanged at $661,000, with a target cash bonus of 100% of base salary
Read the filing on SEC.gov ↗
May 26, 4:40 PM ET
At its May 19, 2026 annual meeting, Omnicell stockholders elected Joanne B. Bauer, Robin G. Seim and Eileen J. Voynick as Class I directors and approved an amendment adding 1,600,000 shares to the 2009 Equity Incentive Plan. They also approved a charter amendment, filed May 20, 2026, that provides officer exculpation from personal liability as permitted by Delaware law, and ratified Deloitte & Touche LLP as auditor for 2026. The share increase expands the number of shares available for issuance under the plan.
- Bauer, Seim and Voynick elected to serve until the 2029 Annual Meeting of Stockholders
- Equity plan amendment approved: 35,182,712 for, 1,472,716 against, 100,392 abstain, 4,704,566 broker non-votes
- Charter amendment approved: 34,320,796 for, 2,419,140 against, 15,884 abstain; filed with Delaware on May 20, 2026
- Deloitte & Touche LLP ratified for the year ending December 31, 2026: 41,224,274 for, 206,940 against
Read the filing on SEC.gov ↗
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.